195 related articles for article (PubMed ID: 23091926)
41. Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update.
Vivarelli M; Montalti R; Risaliti A
World J Gastroenterol; 2013 Nov; 19(42):7316-26. PubMed ID: 24259963
[TBL] [Abstract][Full Text] [Related]
42. Surgical resection and liver transplantation for hepatocellular carcinoma.
Akoad ME; Pomfret EA
Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
[TBL] [Abstract][Full Text] [Related]
43. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
[TBL] [Abstract][Full Text] [Related]
44. Management of the single liver nodule in a cirrhotic patient: a decision analysis model.
El-Serag HB; Mallat DB; Rabeneck L
J Clin Gastroenterol; 2005 Feb; 39(2):152-9. PubMed ID: 15681913
[TBL] [Abstract][Full Text] [Related]
45. Bridging to liver transplantation in HCC patients.
Kollmann D; Selzner N; Selzner M
Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
[TBL] [Abstract][Full Text] [Related]
46. Medical Management of Hepatocellular Carcinoma.
Rich NE; Yopp AC; Singal AG
J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614
[TBL] [Abstract][Full Text] [Related]
47. [Treatment of hepatocellular carcinoma].
Belghiti J
Bull Acad Natl Med; 2012 Jan; 196(1):97-102; discussion 102-3. PubMed ID: 23259337
[TBL] [Abstract][Full Text] [Related]
48. Hepatocellular carcinoma (HCC): an update.
Rougier P; Mitry E; Barbare JC; Taieb J
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S12-20. PubMed ID: 17449346
[TBL] [Abstract][Full Text] [Related]
49. Surgical treatment for hepatocellular carcinoma in cirrhotic patients. Guide to the selection and decision-making process in a context of multimodal strategy.
González HD; Figueras J
Clin Transl Oncol; 2009 Jan; 11(1):20-7. PubMed ID: 19155200
[TBL] [Abstract][Full Text] [Related]
50. Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors.
Celsa C; Cabibbo G; Pagano D; di Marco V; Cammà C; Gruttadauria S
J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1048-1053. PubMed ID: 32668179
[No Abstract] [Full Text] [Related]
51. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
[TBL] [Abstract][Full Text] [Related]
52. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
53. Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation.
Guerrini GP; Berretta M; Tarantino G; Magistri P; Pecchi A; Ballarin R; Di Benedetto F
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3421-3435. PubMed ID: 28829499
[TBL] [Abstract][Full Text] [Related]
54. [Surgical therapy of hepatocellular carcinoma].
Frilling A; Frühauf N; Sotiropoulos GC; Cicinnati V; Malago M; Broelsch CE
Zentralbl Chir; 2003 Nov; 128(11):900-5. PubMed ID: 14669109
[TBL] [Abstract][Full Text] [Related]
55. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
[TBL] [Abstract][Full Text] [Related]
56. Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
Eskens FA; van Erpecum KJ; de Jong KP; van Delden OM; Klumpen HJ; Verhoef C; Jansen PL; van den Bosch MA; Méndez Romero A; Verheij J; Bloemena E; de Man RA
Neth J Med; 2014 Jul; 72(6):299-304. PubMed ID: 25319854
[TBL] [Abstract][Full Text] [Related]
57. Hepatocellular carcinoma: systemic therapies and future perspectives.
Mikhail S; Cosgrove D; Zeidan A
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
[TBL] [Abstract][Full Text] [Related]
58. [Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period].
Popescu I; Ionescu M; Ciurea S; Braşoveanu V; Sârbu-Boeţi P; Hrehoreţ D; Tomulescu V; Alexandrescu S; Dorobanţu B; Grigorie R; Jemna C; Gheorghe L; Anghel R; Croitoru A; Herlea V; Boroş M
Chirurgia (Bucur); 2005; 100(4):321-31. PubMed ID: 16238194
[TBL] [Abstract][Full Text] [Related]
59. [Different strategies for treatment of hepatocellular carcinoma in the west and in the east].
Makuuchi M; Kita Y; Takayama T
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1137-43. PubMed ID: 9679575
[TBL] [Abstract][Full Text] [Related]
60. Multimodal treatment of hepatocellular carcinoma.
Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
